Free Trial
OTCMKTS:VACBF

Nykode Therapeutics AS (VACBF) Stock Price, News & Analysis

$0.52
0.00 (0.00%)
(As of 11/1/2024 ET)

About Nykode Therapeutics AS Stock (OTCMKTS:VACBF)

Key Stats

Today's Range
$0.52
$0.52
50-Day Range
$0.52
$0.53
52-Week Range
$0.52
$0.95
Volume
N/A
Average Volume
500 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Nykode Therapeutics AS, a clinical-stage biopharmaceutical company, discovers and develops novel immunotherapies. The company develops vaccines for the treatment cancer and infectious diseases. Its lead product candidates include VB10.NEO, a cancer neoantigen vaccine, which is in phase I/IIa clinical trial for the treatment of ,melanoma, lung, bladder, renal, head, and neck cancer; VB10.16, a therapeutic vaccine, which in phase II clinical trial for the treatment of human papilloma virus 16 induced malignancies, such as cervical cancer; and VB10. COV2, a COVID-19 vaccine candidate covers new SARS-CoV-2 variants. The company has collaboration agreements with Roche, Genentech, MSD, and Nektar Therapeutics; Adaptive Biotechnologies for T cell vaccine development; and research agreement with Regeneron. Nykode Therapeutics AS was founded in 2006 and is based in Oslo, Norway.

Receive VACBF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nykode Therapeutics AS and its competitors with MarketBeat's FREE daily newsletter.

VACBF Stock News Headlines

Nykode Therapeutics AS (5VB.DU)
625,000% Gain
Imagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market. Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz.
Nykode Therapeutics - Quarterly report Q1 2024
See More Headlines

VACBF Stock Analysis - Frequently Asked Questions

Nykode Therapeutics AS's stock was trading at $1.58 on January 1st, 2024. Since then, VACBF stock has decreased by 67.1% and is now trading at $0.5191.
View the best growth stocks for 2024 here
.

Shares of VACBF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Industry, Sector and Symbol

Sector
Medical
Industry
Biotechnology
Sub-Industry
N/A
Current Symbol
OTCMKTS:VACBF
CIK
N/A
Fax
N/A
Employees
171
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
7 Stocks to Buy And Hold Forever Cover

Click the link below and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report

This page (OTCMKTS:VACBF) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners